— Solid execution in Q3'25 — Constant CurrencyARR Growth of 9.3%; at higher end of guidance range — Operating and Free Cash Flow Growth of 14%; exceeded guidance ranges — Raising guidance for ARR, Free Cash Flow, Revenue, EPS, and Non-GAAP EPS — Proceeding with share repurchases under our $2 billion authorization — Continuing to […]
Achieved Total Net Product Sales of $682 Million Representing 17% Year-Over-Year Growth INGREZZA® (valbenazine) Second-Quarter 2025 Net Product Sales of $624 Million and Narrows 2025 Net Product Sales Guidance to $2.5 – $2.55 Billion CRENESSITY® (crinecerfont) Second-Quarter 2025 Net Product Sales of $53 Million with 664 Total New Patient Enrollment Start Forms Neurocrine Biosciences, Inc.
Freehold Royalties Announces Second Quarter 2025 Results GlobeNewswire July 30, 2025 CALGARY, Alberta, July 30, 2025 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces second quarter results for the period ended June 30, 2025. Second Quarter Highlights $78 million in revenue; $57 million in funds from operations ($0.35/share) (1)(2); $44 million
(NasdaqGM:PRME), CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering of shares of its common stock. Prime Medicine also intends to grant the underwriters a 30-day
(NASDAQ:FORM), LIVERMORE, Calif., July 30, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) today announced its financial results for the second quarter of fiscal 2025 ended June 28, 2025. Quarterly revenues were $195.8 million, an increase of 14.3% compared to $171.4 million in the first quarter of fiscal 2025, and a decrease of 0.8% from
(NasdaqGM:GECC), PALM BEACH GARDENS, Fla., July 30, 2025 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced that it will release its financial results for the second quarter ended June 30, 2025, after the close of market trading on Monday, August 4, 2025. The results
(NASDAQ:CPSH), NORTON, Mass., July 30, 2025 (GLOBE NEWSWIRE) — CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced financial results for the fiscal second quarter ended June 28, 2025. Second Quarter Highlights Revenue of $8.1 million, versus $5.0 million in the prior-year period, reflecting strong demand for the Company's core product lines Gross margin
(NASDAQ:MDXG), Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06, Respectively Second Quarter Adjusted EBITDA was $24 Million, or 25% of Net Sales Raises 2025 Net Sales Growth Expectations Management to Host
(NASDAQ:ALHC), Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA Raises full-year outlook across same four metrics ORANGE, Calif., July 30, 2025 (GLOBE NEWSWIRE)
Prime Medicine Announces Proposed Public Offering of Common Stock GlobeNewswire July 30, 2025 CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering of shares of its